questionsmedicales.fr
Phénomènes génétiques
Structures génétiques
Génome
Composants de génome
Gènes
Gènes tumoraux
Oncogènes
Proto-oncogènes
Proto-oncogènes : Questions médicales fréquentes
Diagnostic
5
Génétique
Séquençage
Tests moléculaires
Biopsie
Imagerie médicale
Tests sanguins
Tests génétiques
Antécédents familiaux
Cancer
Marqueurs tumoraux
HER2
RAS
Imagerie médicale
Tumeurs
Diagnostic
Symptômes
5
Symptômes
Fatigue
Perte de poids
Symptômes
Cancer
Non spécifique
Prolifération cellulaire
Croissance tumorale
Cancer
Symptômes tardifs
Cancer
Proto-oncogènes
Symptômes
Fatigue
Douleur
Prévention
5
Prévention
Tabagisme
Radiations
Alimentation
Prévention du cancer
Fruits et légumes
Dépistage
Prévention
Cancer
Exercice physique
Prévention
Cancer
Vaccination
Prévention
HPV
Traitements
5
Thérapies ciblées
Inhibiteurs de tyrosine kinase
Traitement du cancer
Chimiothérapie
Cancer
Efficacité
Traitement personnalisé
Mutations
Proto-oncogènes
Effets secondaires
Thérapies ciblées
Fatigue
Traitements immunologiques
Cellules tumorales
Proto-oncogènes
Complications
5
Complications
Métastase
Infections
Traitements
Effets secondaires
Complications
Soins palliatifs
Suivi médical
Soutien psychologique
Complications
Prévisibilité
Cancer
Qualité de vie
Complications
Patients
Facteurs de risque
5
Facteurs de risque
Tabagisme
Antécédents familiaux
Âge
Facteurs de risque
Mutations
Infections virales
HPV
Facteurs de risque
Mode de vie
Prévention
Cancer
Facteurs environnementaux
Cancérigènes
Risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Proto-oncogènes : Questions médicales les plus fréquentes",
"headline": "Proto-oncogènes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Proto-oncogènes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-17",
"dateModified": "2026-04-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Proto-oncogènes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Oncogènes",
"url": "https://questionsmedicales.fr/mesh/D009857",
"about": {
"@type": "MedicalCondition",
"name": "Oncogènes",
"code": {
"@type": "MedicalCode",
"code": "D009857",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.375.500"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gènes abl",
"alternateName": "Genes, abl",
"url": "https://questionsmedicales.fr/mesh/D016313",
"about": {
"@type": "MedicalCondition",
"name": "Gènes abl",
"code": {
"@type": "MedicalCode",
"code": "D016313",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.375.500.791.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes bcl-1",
"alternateName": "Genes, bcl-1",
"url": "https://questionsmedicales.fr/mesh/D019940",
"about": {
"@type": "MedicalCondition",
"name": "Gènes bcl-1",
"code": {
"@type": "MedicalCode",
"code": "D019940",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.375.500.791.148"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes bcl-2",
"alternateName": "Genes, bcl-2",
"url": "https://questionsmedicales.fr/mesh/D019254",
"about": {
"@type": "MedicalCondition",
"name": "Gènes bcl-2",
"code": {
"@type": "MedicalCode",
"code": "D019254",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.375.500.791.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes erbA",
"alternateName": "Genes, erbA",
"url": "https://questionsmedicales.fr/mesh/D018776",
"about": {
"@type": "MedicalCondition",
"name": "Gènes erbA",
"code": {
"@type": "MedicalCode",
"code": "D018776",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.375.500.791.290"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes erbB",
"alternateName": "Genes, erbB",
"url": "https://questionsmedicales.fr/mesh/D018815",
"about": {
"@type": "MedicalCondition",
"name": "Gènes erbB",
"code": {
"@type": "MedicalCode",
"code": "D018815",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.375.500.791.295"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gènes erbB-1",
"alternateName": "Genes, erbB-1",
"url": "https://questionsmedicales.fr/mesh/D018773",
"about": {
"@type": "MedicalCondition",
"name": "Gènes erbB-1",
"code": {
"@type": "MedicalCode",
"code": "D018773",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.375.500.791.295.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes erbB-2",
"alternateName": "Genes, erbB-2",
"url": "https://questionsmedicales.fr/mesh/D018734",
"about": {
"@type": "MedicalCondition",
"name": "Gènes erbB-2",
"code": {
"@type": "MedicalCode",
"code": "D018734",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.375.500.791.295.305"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Gènes fms",
"alternateName": "Genes, fms",
"url": "https://questionsmedicales.fr/mesh/D016236",
"about": {
"@type": "MedicalCondition",
"name": "Gènes fms",
"code": {
"@type": "MedicalCode",
"code": "D016236",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.375.500.791.325"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes fos",
"alternateName": "Genes, fos",
"url": "https://questionsmedicales.fr/mesh/D016762",
"about": {
"@type": "MedicalCondition",
"name": "Gènes fos",
"code": {
"@type": "MedicalCode",
"code": "D016762",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.375.500.791.330"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes jun",
"alternateName": "Genes, jun",
"url": "https://questionsmedicales.fr/mesh/D016758",
"about": {
"@type": "MedicalCondition",
"name": "Gènes jun",
"code": {
"@type": "MedicalCode",
"code": "D016758",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.375.500.791.365"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes mos",
"alternateName": "Genes, mos",
"url": "https://questionsmedicales.fr/mesh/D016258",
"about": {
"@type": "MedicalCondition",
"name": "Gènes mos",
"code": {
"@type": "MedicalCode",
"code": "D016258",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.375.500.791.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes myb",
"alternateName": "Genes, myb",
"url": "https://questionsmedicales.fr/mesh/D020570",
"about": {
"@type": "MedicalCondition",
"name": "Gènes myb",
"code": {
"@type": "MedicalCode",
"code": "D020570",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.375.500.791.418"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes myc",
"alternateName": "Genes, myc",
"url": "https://questionsmedicales.fr/mesh/D016259",
"about": {
"@type": "MedicalCondition",
"name": "Gènes myc",
"code": {
"@type": "MedicalCode",
"code": "D016259",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.375.500.791.420"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes ras",
"alternateName": "Genes, ras",
"url": "https://questionsmedicales.fr/mesh/D011905",
"about": {
"@type": "MedicalCondition",
"name": "Gènes ras",
"code": {
"@type": "MedicalCode",
"code": "D011905",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.375.500.791.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes rel",
"alternateName": "Genes, rel",
"url": "https://questionsmedicales.fr/mesh/D020573",
"about": {
"@type": "MedicalCondition",
"name": "Gènes rel",
"code": {
"@type": "MedicalCode",
"code": "D020573",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.375.500.791.552"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes sis",
"alternateName": "Genes, sis",
"url": "https://questionsmedicales.fr/mesh/D020571",
"about": {
"@type": "MedicalCondition",
"name": "Gènes sis",
"code": {
"@type": "MedicalCode",
"code": "D020571",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.375.500.791.560"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Gènes src",
"alternateName": "Genes, src",
"url": "https://questionsmedicales.fr/mesh/D016391",
"about": {
"@type": "MedicalCondition",
"name": "Gènes src",
"code": {
"@type": "MedicalCode",
"code": "D016391",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.375.500.791.570"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Proto-oncogènes",
"alternateName": "Proto-Oncogenes",
"code": {
"@type": "MedicalCode",
"code": "D011519",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yan Wang",
"url": "https://questionsmedicales.fr/author/Yan%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China."
}
},
{
"@type": "Person",
"name": "Johanna Stachelscheid",
"url": "https://questionsmedicales.fr/author/Johanna%20Stachelscheid",
"affiliation": {
"@type": "Organization",
"name": "Department I of Internal Medicine, Center for Integrated Oncology (CIO), Aachen-Bonn-Cologne-Duesseldorf, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany."
}
},
{
"@type": "Person",
"name": "Qu Jiang",
"url": "https://questionsmedicales.fr/author/Qu%20Jiang",
"affiliation": {
"@type": "Organization",
"name": "Department I of Internal Medicine, Center for Integrated Oncology (CIO), Aachen-Bonn-Cologne-Duesseldorf, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany."
}
},
{
"@type": "Person",
"name": "Marco Herling",
"url": "https://questionsmedicales.fr/author/Marco%20Herling",
"affiliation": {
"@type": "Organization",
"name": "Department I of Internal Medicine, Center for Integrated Oncology (CIO), Aachen-Bonn-Cologne-Duesseldorf, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany."
}
},
{
"@type": "Person",
"name": "André Miranda",
"url": "https://questionsmedicales.fr/author/Andr%C3%A9%20Miranda",
"affiliation": {
"@type": "Organization",
"name": "CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal; Centre for Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Inov4Agro, University of Trás-os-Montes and Alto Douro (UTAD), Quinta de Prados, 5000-801 Vila Real, Portugal."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Proto-oncogene mutations in middle ear cholesteatoma contribute to its pathogenesis.",
"datePublished": "2023-11-15",
"url": "https://questionsmedicales.fr/article/37968650",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12920-023-01640-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "The proto-oncogene SRC phosphorylates cGAS to inhibit an antitumor immune response.",
"datePublished": "2023-06-22",
"url": "https://questionsmedicales.fr/article/37166992",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1172/jci.insight.167270"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinic Heterogeneity and Management of Pediatric Patients With Germline RET Proto-oncogene Mutation: Single-center Experience.",
"datePublished": "2023-07-24",
"url": "https://questionsmedicales.fr/article/37526376",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MPH.0000000000002728"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genes with dual proto-oncogene and tumor suppressor gene activities are frequently altered by protein losses in colon cancers.",
"datePublished": "2023-06-30",
"url": "https://questionsmedicales.fr/article/37429176",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.prp.2023.154659"
}
},
{
"@type": "ScholarlyArticle",
"name": "Laser nanostructured gold biosensor for proto-oncogene detection.",
"datePublished": "2023-10-11",
"url": "https://questionsmedicales.fr/article/37821490",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-44372-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Génome",
"item": "https://questionsmedicales.fr/mesh/D016678"
},
{
"@type": "ListItem",
"position": 5,
"name": "Composants de génome",
"item": "https://questionsmedicales.fr/mesh/D040481"
},
{
"@type": "ListItem",
"position": 6,
"name": "Gènes",
"item": "https://questionsmedicales.fr/mesh/D005796"
},
{
"@type": "ListItem",
"position": 7,
"name": "Gènes tumoraux",
"item": "https://questionsmedicales.fr/mesh/D052138"
},
{
"@type": "ListItem",
"position": 8,
"name": "Oncogènes",
"item": "https://questionsmedicales.fr/mesh/D009857"
},
{
"@type": "ListItem",
"position": 9,
"name": "Proto-oncogènes",
"item": "https://questionsmedicales.fr/mesh/D011519"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Proto-oncogènes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Proto-oncogènes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Proto-oncogènes",
"description": "Comment détecte-t-on les mutations des proto-oncogènes ?\nQuels tests sont utilisés pour le diagnostic du cancer lié aux proto-oncogènes ?\nLes tests génétiques sont-ils recommandés pour tous les cancers ?\nQuels marqueurs tumoraux sont associés aux proto-oncogènes ?\nPeut-on identifier les proto-oncogènes par imagerie ?",
"url": "https://questionsmedicales.fr/mesh/D011519#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Proto-oncogènes",
"description": "Quels symptômes peuvent indiquer une activation des proto-oncogènes ?\nLes symptômes sont-ils spécifiques aux proto-oncogènes ?\nComment les proto-oncogènes affectent-ils la croissance tumorale ?\nLes symptômes peuvent-ils apparaître tardivement ?\nY a-t-il des symptômes communs à plusieurs cancers ?",
"url": "https://questionsmedicales.fr/mesh/D011519#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Proto-oncogènes",
"description": "Peut-on prévenir les mutations des proto-oncogènes ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLes dépistages réguliers aident-ils à prévenir le cancer ?\nL'exercice physique peut-il réduire le risque de cancer ?\nLes vaccinations peuvent-elles prévenir certains cancers ?",
"url": "https://questionsmedicales.fr/mesh/D011519#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Proto-oncogènes",
"description": "Quels traitements ciblent les proto-oncogènes ?\nLa chimiothérapie est-elle efficace contre les cancers liés aux proto-oncogènes ?\nLes traitements sont-ils personnalisés selon les proto-oncogènes ?\nQuels sont les effets secondaires des traitements ciblés ?\nLes traitements immunologiques sont-ils efficaces contre les proto-oncogènes ?",
"url": "https://questionsmedicales.fr/mesh/D011519#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Proto-oncogènes",
"description": "Quelles complications peuvent survenir avec les cancers liés aux proto-oncogènes ?\nLes traitements peuvent-ils entraîner des complications ?\nComment gérer les complications liées aux cancers ?\nLes complications sont-elles prévisibles ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D011519#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Proto-oncogènes",
"description": "Quels sont les principaux facteurs de risque pour les proto-oncogènes ?\nL'âge est-il un facteur de risque pour les cancers liés aux proto-oncogènes ?\nLes infections virales sont-elles des facteurs de risque ?\nLe mode de vie influence-t-il le risque de cancer ?\nLes facteurs environnementaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D011519#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecte-t-on les mutations des proto-oncogènes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les mutations peuvent être détectées par séquençage génétique et tests moléculaires."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic du cancer lié aux proto-oncogènes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les biopsies, l'imagerie et les tests sanguins sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils recommandés pour tous les cancers ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils sont recommandés selon l'historique familial et le type de cancer."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont associés aux proto-oncogènes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme HER2 et RAS sont souvent associés à des proto-oncogènes."
}
},
{
"@type": "Question",
"name": "Peut-on identifier les proto-oncogènes par imagerie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie ne détecte pas directement les proto-oncogènes, mais les tumeurs associées."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une activation des proto-oncogènes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes varient selon le cancer, incluant fatigue, perte de poids et douleurs."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils spécifiques aux proto-oncogènes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les symptômes sont souvent non spécifiques et peuvent varier selon le type de cancer."
}
},
{
"@type": "Question",
"name": "Comment les proto-oncogènes affectent-ils la croissance tumorale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils favorisent la prolifération cellulaire, conduisant à une croissance tumorale incontrôlée."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils apparaître tardivement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreux cancers liés aux proto-oncogènes présentent des symptômes tardifs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes communs à plusieurs cancers ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la fatigue et la douleur peuvent être communs à plusieurs cancers."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les mutations des proto-oncogènes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines mesures, comme éviter le tabac et l'exposition aux radiations, peuvent aider."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en fruits et légumes peut réduire le risque de cancer."
}
},
{
"@type": "Question",
"name": "Les dépistages réguliers aident-ils à prévenir le cancer ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les dépistages peuvent détecter précocement des cancers liés aux proto-oncogènes."
}
},
{
"@type": "Question",
"name": "L'exercice physique peut-il réduire le risque de cancer ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier est associé à un risque réduit de plusieurs types de cancer."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles prévenir certains cancers ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations, comme contre le HPV, peuvent prévenir des cancers spécifiques."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les proto-oncogènes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies ciblées, comme les inhibiteurs de tyrosine kinase, ciblent les proto-oncogènes."
}
},
{
"@type": "Question",
"name": "La chimiothérapie est-elle efficace contre les cancers liés aux proto-oncogènes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chimiothérapie peut être utilisée, mais son efficacité dépend du type de cancer."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés selon les proto-oncogènes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être personnalisés en fonction des mutations spécifiques."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ciblés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des éruptions cutanées et de la fatigue."
}
},
{
"@type": "Question",
"name": "Les traitements immunologiques sont-ils efficaces contre les proto-oncogènes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains traitements immunologiques peuvent cibler les cellules tumorales liées aux proto-oncogènes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les cancers liés aux proto-oncogènes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la métastase, l'insuffisance organique et les infections."
}
},
{
"@type": "Question",
"name": "Les traitements peuvent-ils entraîner des complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent causer des effets secondaires graves et des complications."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées aux cancers ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut des soins palliatifs, un suivi médical et un soutien psychologique."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être anticipées, mais d'autres peuvent survenir de manière imprévisible."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour les proto-oncogènes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'exposition aux radiations et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour les cancers liés aux proto-oncogènes ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de cancer augmente généralement avec l'âge en raison de mutations accumulées."
}
},
{
"@type": "Question",
"name": "Les infections virales sont-elles des facteurs de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections virales, comme le HPV, augmentent le risque de cancer."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque de cancer ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque de cancer lié aux proto-oncogènes."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des substances cancérigènes dans l'environnement augmente le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 07/04/2026
Contenu vérifié selon les dernières recommandations médicales
└─
Gènes abl
Genes, abl
D016313 -
G05.360.340.024.340.375.500.791.100
└─
Gènes bcl-1
Genes, bcl-1
D019940 -
G05.360.340.024.340.375.500.791.148
└─
Gènes bcl-2
Genes, bcl-2
D019254 -
G05.360.340.024.340.375.500.791.150
└─
Gènes erbA
Genes, erbA
D018776 -
G05.360.340.024.340.375.500.791.290
└─
Gènes erbB
Genes, erbB
D018815 -
G05.360.340.024.340.375.500.791.295
└─
Gènes fms
Genes, fms
D016236 -
G05.360.340.024.340.375.500.791.325
└─
Gènes fos
Genes, fos
D016762 -
G05.360.340.024.340.375.500.791.330
└─
Gènes jun
Genes, jun
D016758 -
G05.360.340.024.340.375.500.791.365
└─
Gènes mos
Genes, mos
D016258 -
G05.360.340.024.340.375.500.791.400
└─
Gènes myb
Genes, myb
D020570 -
G05.360.340.024.340.375.500.791.418
└─
Gènes myc
Genes, myc
D016259 -
G05.360.340.024.340.375.500.791.420
└─
Gènes ras
Genes, ras
D011905 -
G05.360.340.024.340.375.500.791.550
└─
Gènes rel
Genes, rel
D020573 -
G05.360.340.024.340.375.500.791.552
└─
Gènes sis
Genes, sis
D020571 -
G05.360.340.024.340.375.500.791.560
└─
Gènes src
Genes, src
D016391 -
G05.360.340.024.340.375.500.791.570
└─└─
Gènes erbB-1
Genes, erbB-1
D018773 -
G05.360.340.024.340.375.500.791.295.300
└─└─
Gènes erbB-2
Genes, erbB-2
D018734 -
G05.360.340.024.340.375.500.791.295.305
3 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Publications dans "Proto-oncogènes" :
2 publications dans cette catégorie
Affiliations :
Department I of Internal Medicine, Center for Integrated Oncology (CIO), Aachen-Bonn-Cologne-Duesseldorf, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany.
Publications dans "Proto-oncogènes" :
2 publications dans cette catégorie
Affiliations :
Department I of Internal Medicine, Center for Integrated Oncology (CIO), Aachen-Bonn-Cologne-Duesseldorf, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany.
Publications dans "Proto-oncogènes" :
2 publications dans cette catégorie
Affiliations :
Department I of Internal Medicine, Center for Integrated Oncology (CIO), Aachen-Bonn-Cologne-Duesseldorf, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany.
Department of Hematology, Cellular Therapy, and Hemostaseology, University of Leipzig, 04103 Leipzig, Germany.
Publications dans "Proto-oncogènes" :
2 publications dans cette catégorie
Affiliations :
CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal; Centre for Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Inov4Agro, University of Trás-os-Montes and Alto Douro (UTAD), Quinta de Prados, 5000-801 Vila Real, Portugal.
Publications dans "Proto-oncogènes" :
2 publications dans cette catégorie
Affiliations :
CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal; Departamento de Química, Universidade da Beira Interior, Rua Marquês de Ávila e Bolama, 6201-001 Covilhã, Portugal. Electronic address: carlacruz@fcsaude.ubi.pt.
Publications dans "Proto-oncogènes" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, 361102, Fujian, China.
Publications dans "Proto-oncogènes" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, 361102, Fujian, China.
Publications dans "Proto-oncogènes" :
2 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, UT Health San Antonio, San Antonio, TX 78229, USA.
Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, China.
Publications dans "Proto-oncogènes" :
2 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, UT Health San Antonio, San Antonio, TX 78229, USA.
Mays Cancer Canter, UT Health San Antonio, San Antonio, TX 78229, USA.
Publications dans "Proto-oncogènes" :
2 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, UT Health San Antonio, San Antonio, TX 78229, USA.
Department of Oncology, Xiangya Hospital, Central South University, Changsha 410008, China.
Publications dans "Proto-oncogènes" :
2 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, UT Health San Antonio, San Antonio, TX 78229, USA.
Mays Cancer Canter, UT Health San Antonio, San Antonio, TX 78229, USA.
Publications dans "Proto-oncogènes" :
2 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, UT Health San Antonio, San Antonio, TX 78229, USA.
Mays Cancer Canter, UT Health San Antonio, San Antonio, TX 78229, USA.
Publications dans "Proto-oncogènes" :
2 publications dans cette catégorie
Affiliations :
Department of Obstetrics and Gynecology, UT Health San Antonio, San Antonio, TX 78229, USA.
Mays Cancer Canter, UT Health San Antonio, San Antonio, TX 78229, USA.
Audie L. Murphy Division, South Texas Veterans Health Care System, San Antonio, TX 78229, USA.
Publications dans "Proto-oncogènes" :
2 publications dans cette catégorie
Affiliations :
Liver Diseases Department, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Publications dans "Proto-oncogènes" :
2 publications dans cette catégorie
Affiliations :
Department of Traumatic Orthopaedics, Anhui Provincial Hospital, Anhui Medical University, Hefei, Anhui 230000, P.R. China.
Publications dans "Proto-oncogènes" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2V 1P9, Canada.
Publications dans "Proto-oncogènes" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2V 1P9, Canada.
Publications dans "Proto-oncogènes" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2V 1P9, Canada.
Alberta Precision Laboratories, Calgary, AB T2V 1P9, Canada.
Publications dans "Proto-oncogènes" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2V 1P9, Canada.
Alberta Precision Laboratories, Calgary, AB T2V 1P9, Canada.
Publications dans "Proto-oncogènes" :
Chronic inflammation causes bone destruction in middle ear cholesteatomas (MECs). However, the causes of their neoplastic features remain unknown. The present study demonstrated for the first time tha...
DNA was extracted from MEC and blood samples of five patients to detect somatic mutations using depth-depth exome sequencing. Exons with somatic variants were analyzed using an additional 17 MEC/blood...
This is the first study to demonstrate a relationship between neoplastic features of MEC and proto-oncogene mutations....
Cyclic GMP-AMP synthase (cGAS) is a DNA sensor and responsible for inducing an antitumor immune response. Recent studies reveal that cGAS is frequently inhibited in cancer, and therapeutic targets to ...
Inherited forms of medullary thyroid carcinoma (MTC) can cause serious problems in diagnosis and follow-up. Family screening is performed, and prophylactic thyroidectomy at an appropriate age can be l...
Cancer genes are largely categorized into tumor suppressor gene (TSG) and proto-oncogene, but many have dual activities depending on the cellular context. In the present study, we analyzed DYRK1B, ESR...
The advancement of biosensor research has been a primary driving force in the continuing progress of modern medical science. While traditional nanofabrication methods have long been the foundation of ...
In the early 1990's a group of unrelated genes were identified from the sites of recurring translocations in B-cell lymphomas. Despite sharing the nomenclature 'Bcl', and an association with blood-bor...
Ionizing radiation generates genomic instability by promoting the accumulation of chromosomal rearrangements. The oncogenic translocation RET/PTC1 is present in more than 70% of radiation-induced thyr...
We analyzed the dynamic of DNA replication in human thyroid epithelial cells (HThy-ori-3.1) 4 days post a 5-Gy exposure using molecular DNA combing. The DNA replication schedule was evaluated through ...
Our study indicates that replicative stress, occurring several days post-irradiation in thyroid cells, primarily causes DSBs in the RET gene. We discovered that both the RET and CCDC6 genes undergo la...
The findings suggest that post-irradiation in the RET gene causes a breakage in the replication fork, which could potentially invade another genomic area, including CCDC6. As a result, this could grea...
To combat cancer, a comprehensive understanding of the molecular mechanisms and behaviors involved in carcinogenesis is crucial, as tumorigenesis is a complex process influenced by various genetic eve...
The combination of radiotherapy and immunotherapy (immunoradiotherapy) has been increasingly used for treating a wide range of cancers. However, some tumors are resistant to immunoradiotherapy. We hav...
344SQR cells were injected into the right legs on day 0 and the left legs on day 4 of 8-12 weeks old female 129sv/ev mice to establish primary and secondary tumors, respectively. Radiation at a dose o...
Remarkably, the addition of MerTK ASO to XRT+anti-PD1 and XRT+anti-CTLA4 profoundly slowed the growth of both primary and secondary tumors and significantly extended survival. The ASO significantly re...
The MerTK ASO can significantly downregulate the expression of MerTK on TAMs, thereby promoting antitumor immune response. The combination of MerTK ASO with immunoradiotherapy can safely and significa...
The role of neutrophils in breast cancer shows that the N1 proinflammatory subtype can suppress and attack the tumor. In contrast, the N2 pro-tumor subtype aids the tumor in its survival, progression,...